UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017118
Receipt number R000019860
Scientific Title A randomized, double blind, placebo-controlled trial of zinc and astaxanthin among mild glucose intolerance
Date of disclosure of the study information 2015/04/13
Last modified on 2016/04/13 10:08:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A randomized, double blind, placebo-controlled trial of zinc and astaxanthin among mild glucose intolerance

Acronym

A randomized, double blind, placebo-controlled trial of zinc and astaxanthin among mild glucose intolerance

Scientific Title

A randomized, double blind, placebo-controlled trial of zinc and astaxanthin among mild glucose intolerance

Scientific Title:Acronym

A randomized, double blind, placebo-controlled trial of zinc and astaxanthin among mild glucose intolerance

Region

Japan


Condition

Condition

mild glucose intolerance

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the efficacy of taking zinc and astaxanthin on mild glucose intolerance

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

HbA1c,GA

Key secondary outcomes

AIS,PSQI,CESD,SF8,sleep log
Actigraph
T-C,HDL-C,LDL-C,TG
BUN,s-cre,e-GFR
Zn
Blood pressure
BMI


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

4

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

placebo

Interventions/Control_2

zinc

Interventions/Control_3

zinc and astaxanthin

Interventions/Control_4

zinc and astaxanthin

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >

Gender

Male and Female

Key inclusion criteria

Level of GA: 15.6%-18.3%

Key exclusion criteria

diabetic disease
current use of substances or medications known to affect sleep, including prescription psychotropics, sedatives, hypnotics

Target sample size

120


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yuichi Inoue

Organization

Tokyo Medical University

Division name

Department of Somnology

Zip code


Address

Shinjuku, Shinjuku-ku, Tokyo

TEL

03-3351-6141

Email

ykoma@tokyo-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yoko Komada

Organization

Tokyo Medical University

Division name

Department of Somnology

Zip code


Address

Shinjuku, Shinjuku-ku, Tokyo

TEL

03-3351-6141

Homepage URL


Email

ykoma@tokyo-med.ac.jp


Sponsor or person

Institute

Tokyo Medical University

Institute

Department

Personal name



Funding Source

Organization

Research Project on Development of Agricultural Products and Foods
with Health-promoting benefits (NARO)

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 04 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2015 Year 02 Month 02 Day

Date of IRB


Anticipated trial start date

2015 Year 02 Month 02 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 04 Month 13 Day

Last modified on

2016 Year 04 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019860


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name